Literature DB >> 21688019

The coexistence of type 1 diabetes, MODY2 and metabolic syndrome in a young girl.

Valeria Calcaterra1, Miryam Martinetti, Alessandro Salina, Concetta Aloi, Daniela Larizza.   

Abstract

Even though autoantibodies to pancreatic islet cells are normally found in type 1 diabetes and insulin-resistance due to overweight is more reminiscent of type 2 diabetes, some studies have described β-cell antibodies also in maturity-onset diabetes of the young (MODY) and in type 2 diabetes. A 7-year-old girl was referred to our Unit for incidental hyperglycemia and family history of MODY2 and type 2 diabetes. Genetic evaluation confirmed mutation L134P in exon 4 of the glucokinase gene and a high HLA-risk of type 1 diabetes. During follow-up, she developed type 1 diabetes and overweight-induced metabolic syndrome. The coexistence of MODY, type 1 diabetes and overweight-induced metabolic syndrome confirms that diabetes subtype probably represents a continuum of immune and metabolic dysfunction modified by genetic factors.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21688019     DOI: 10.1007/s00592-011-0300-2

Source DB:  PubMed          Journal:  Acta Diabetol        ISSN: 0940-5429            Impact factor:   4.280


  3 in total

1.  A glucokinase gene mutation in a young boy with diabetes mellitus, hyperinsulinemia, and insulin resistance.

Authors:  Andrey O Emelyanov; Elena Sechko; Ekaterina Koksharova; Igor Sklyanik; Tamara Kuraeva; Alexander Mayorov; Valentina Peterkova; Ivan Dedov
Journal:  Int Med Case Rep J       Date:  2017-03-07

2.  Phenotypic and Genetic Heterogeneity in a Thai Glucokinase MODY Family Reveals the Complexity of Young-Onset Diabetes.

Authors:  Yotsapon Thewjitcharoen; Ekgaluck Wanothayaroj; Sirinate Krittiyawong; Soontaree Nakasatien; Tsz Fung Tsoi; Cadmon K P Lim; Juliana C N Chan; Thep Himathongkam
Journal:  Front Endocrinol (Lausanne)       Date:  2021-09-01       Impact factor: 5.555

3.  Less but better: cardioprotective lipid profile of patients with GCK-MODY despite lower HDL cholesterol level.

Authors:  Wojciech Fendler; Manfredi Rizzo; Maciej Borowiec; Beata Malachowska; Karolina Antosik; Agnieszka Szadkowska; Maciej Banach; Malgorzata Urbanska-Kosinska; Magdalena Szopa; Maciej Malecki; Wojciech Mlynarski
Journal:  Acta Diabetol       Date:  2014-02-19       Impact factor: 4.280

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.